Horizon Therapeutics USA, Inc. (Fka… — Receipts Report
Foreign owner disclosed
Lobbying client · LD-2 disclosures
Horizon Therapeutics USA, Inc. (Fka Horizon Pharma USA, Inc.)
Illinois
67 filings from 2 registrants · 2015–2024 · latest filed Feb 15, 2024
Reported on its behalf
$38.1M
every LD-2 on file
Its own filed spend
$36.7M
lobbying for itself
Fees to outside firms
$1.4M
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
Horizon Therapeutics USA, Inc. (Fka Horizon Pharma USA, Inc.)
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: horizon-therapeutics-usa-inc-fka-horizon-pharma-usa-inc.
Reading this · LD-2 reports a hired firm's fee and a registrant's reported expenses on separate lines and never both on one filing, so the two lists above are different quantities and are ranked separately rather than against each other. Firm names link to their own record as the firms chapter lands.
15 filings
$600K on those filings
Government Issues
GOV
1 filing
$910K on those filings
Copyright/Patent/Trademark
CPT
1 filing
$220K on those filings
Small Business
SMB
1 filing
$220K on those filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore spend on filings that named this issue — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
117th Congress
An act to provide for reconciliation pursuant to title II of S. Con. Res. 14.
7 filingsthrough 2022
H.R. 6963117th CongressAccelerated Approval Integrity Act of 20225 filingsthrough 2022
S.Con.Res. 14117th CongressA concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.5 filingsthrough 2022
H.Res. 242116th CongressAffirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases.5 filingsthrough 2020
H.R. 1425117th CongressTo amend the Internal Revenue Code of 1986 to repeal the limitation on the cover over of distilled spirits taxes to the Virgin Islands and Puerto Rico.4 filingsthrough 2021
H.R. 3173117th CongressImproving Seniors’ Timely Access to Care Act of 20224 filingsthrough 2022
H.R. 1503116th CongressOrange Book Transparency Act of 20204 filingsthrough 2019
H.R. 2113116th CongressPrescription Drug STAR Act4 filingsthrough 2020
How these are found · Bill references are extracted from the free-text activity description each filing writes, then matched to the Congress in session that filing year. A reference we can't match to a bill on file is still shown, unlinked — we cite what the filing said rather than guess at what it meant. Naming a bill is not a position on it: LD-2 records that a client lobbied on the bill, never which side.
Covered position: Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President
28 filingsthrough 2023
Eli KoganHorizon Therapeutics USA, Inc. (Fka Horizon Pharma USA, Inc.)Covered position: Off of Rep Joe Crowley: Senior Legis Asst, Legis Asst, Legis Aide, Legis Correspondent27 filingsthrough 2023
Jordan ChapmanHorizon Therapeutics USA, Inc. (Fka Horizon Pharma USA, Inc.)24 filingsthrough 2023
Brenton J FiskHorizon Therapeutics USA, Inc. (Fka Horizon Pharma USA, Inc.)23 filingsthrough 2023
Kenneth Lee HodgeJeffrey J. Kimbell & Associates, Inc.16 filingsthrough 2023
John R RayJeffrey J. Kimbell & Associates, Inc.Covered position: Legislative Assistant, Rep. Mike Kelly15 filingsthrough 2023
David RudloffJeffrey J. Kimbell & Associates, Inc.15 filingsthrough 2023
Parul PatelHorizon Therapeutics USA, Inc. (Fka Horizon Pharma USA, Inc.)15 filingsthrough 2021
Marilyn VetterHorizon Therapeutics USA, Inc. (Fka Horizon Pharma USA, Inc.)9 filingsthrough 2017
Matt McmurrayHorizon Therapeutics USA, Inc. (Fka Horizon Pharma USA, Inc.)Covered position: Chief Staff, Leg Dir, Snr Leg Asst for Rep A Eshoo; Leg Asst, Leg Correspondent, Staff Asst, Intern for Rep L Slaughter6 filingsthrough 2023
Kelsey CarlsonJeffrey J. Kimbell & Associates, Inc.Covered position: Special Assistant, National Security Council; Special Assistant, International Trade Administration, Dept of Commerce; Policy Advisor, Office of the Deputy Chief of Staff, Executive Office of the President; Confidential Assistant, Dept of Commerce2 filingsthrough 2023
Covered positions · 6 of 15 lobbyists named on these filings disclosed a prior government post. The text is reproduced exactly as filed.
